The pharmacokinetics of edoxaban for the prevention and treatment of venous thromboembolism

作者
Ginés Escolar,Maribel Díaz‐Ricart,Eduardo Arellano‐Rodrigo,Ana M. Galán
出处
期刊:Expert Opinion on Drug Metabolism & Toxicology [Taylor & Francis]
卷期号:10 (3): 445-458 被引量:6
标识
DOI:10.1517/17425255.2014.882897
摘要

INTRODUCTION: Thromboembolic diseases will become the most important contributors to mortality and morbidity for modern societies. Current antithrombotic strategies using heparins or vitamin K antagonists are inconvenient, with limitations and inherent side effects. A series of new oral anticoagulants with powerful and reliable antithrombotic actions have been developed in the last decade. AREAS COVERED: Edoxaban is a direct and specific inhibitor of activated factor X, delivered orally. This article reviews literature from PubMed and articles referenced within. The text explores the pharmacological aspects of its antithrombotic action. Pharmacokinetics, metabolism and drug interactions are examined. The review places the results of recent clinical trials that have evaluated the antithrombotic potential of edoxaban versus standard antithrombotic therapies in the prophylaxis and treatment of venous thromboembolism into perspective. The possible relationship between the pharmacokinetic profile of edoxaban and the favorable results in clinical trials is discussed. EXPERT OPINION: Edoxaban is perceived as a major advance, compared to vitamin K antagonists, in the prevention and treatment of thromboembolic disease given its favorable efficacy, safety, pharmacokinetic profile and renal clearance. The results of ongoing large international trials exploring the prevention of thrombotic complications in patients in different clinical settings should ensure the approval of edoxaban to treat new indications.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
开心枣枣完成签到 ,获得积分10
刚刚
1秒前
3秒前
科目三的应助被MiyaGuo采纳,获得10
3秒前
哈妮s完成签到,获得积分10
3秒前
Dreamer发布了新的文献求助10
3秒前
科研通AI6.2的应助被Frank采纳,获得10
3秒前
热情松鼠完成签到,获得积分20
4秒前
5秒前
辛勤怜寒完成签到 ,获得积分10
6秒前
hzzzzz发布了新的文献求助10
6秒前
7秒前
友好的冰巧完成签到,获得积分10
8秒前
8秒前
lmy的应助被xxdwyd采纳,获得10
9秒前
科研通AI6.3的应助被tlc_191026采纳,获得10
9秒前
xx发布了新的文献求助10
9秒前
9秒前
9秒前
10秒前
10秒前
10秒前
11秒前
坦率恶天完成签到,获得积分10
12秒前
111发布了新的文献求助10
12秒前
ding的应助被六六大顺采纳,获得10
12秒前
Olive发布了新的文献求助10
13秒前
14秒前
郑睿涛发布了新的文献求助10
14秒前
14秒前
14秒前
15秒前
15秒前
科研通AI2S的应助被牧百川采纳,获得10
15秒前
科小研发布了新的文献求助10
15秒前
15秒前
冷冷子发布了新的文献求助10
16秒前
热情松鼠发布了新的文献求助10
16秒前
yzh发布了新的文献求助30
17秒前
无极微光的应助被曲昊采纳,获得20
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183508
求助须知:如何正确求助?哪些是违规求助? 9572862
关于积分的说明 21827639
捐赠科研通 7780681
什么是DOI,文献DOI怎么找? 3434016
关于科研通互助平台的介绍 2558189
邀请新用户注册赠送积分活动 2480405